Description
Formestaneisasteroidalandrogensubstratethatinhibitsaromatase.FormestaneisclinicallyusedtotreatER+breastcancer,asitinhibitsproductionofestrogens.
Formestaneisasteroidalandrogensubstratethatinhibitsaromatase.FormestaneisclinicallyusedtotreatER+breastcancer,asitinhibitsproductionofestrogens.
| CasNo. | 566-48-3 |
|---|---|
| Purity | ≥98% |
| Formula | C19H26O3 |
| FormulaWt. | 302.41 |
| ChemicalName | 4-Hydroxyandrost-4-ene-3,17-dione |
| IUPACName | (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione |
| Synonym | 4-OHA;Lentaron |
| MeltingPoint | 199-202°C |
| Solubility | Solubleinmethanol. |
| Appearance | WhiteCrystallinePowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | F5769MSDSPDF |
|---|---|
| InfoSheet | F5769InfoSheetPDF |
MillerWR.Aromataseinhibitors:mechanismofactionandroleinthetreatmentofbreastcancer.SeminOncol.2003Aug;30(4Suppl14):3-11.PMID:14513432.
DowsettM.Aromataseinhibition:basicconcepts,andthepharmacodynamicsofformestane.AnnOncol.1994;5Suppl7:S3-5.PMID:7873460.